New Scale Measures Pros & Cons of Insulin Pumps for T1D

What Was This Study About?

Researchers tested a new survey tool called the Automated Insulin Delivery Benefits and Burdens Scale (AID-BBS). It was designed to measure how adults with Type 1 diabetes (T1D) feel about using automated insulin delivery (AID) systems — often called 'closed-loop' or 'artificial pancreas' systems.

What Is an Automated Insulin Delivery System?

An AID system combines a continuous glucose monitor (CGM) with an insulin pump. The devices talk to each other and automatically adjust insulin doses to help keep blood sugar in a healthy range.

How Was the Study Done?

A total of 217 adults with T1D, aged 18 to 82, took part in a clinical trial. They completed the AID-BBS survey at two points — 6 weeks into the trial and again at 13 weeks (the end). Researchers also collected blood sugar data and other wellbeing questionnaires.

What Did They Find?

The survey proved to be a reliable and valid tool. It has two parts:

• 15 questions about benefits — things like improved sleep, less worry, and better blood sugar control
• 9 questions about burdens — things like device alarms, skin irritation, or feeling tied to the technology

Importantly, how patients scored at 6 weeks predicted whether they would want to keep using the AID system at 13 weeks — even more than blood sugar results alone.

Why Does This Matter for Patients?

This survey gives doctors a practical way to understand your personal experience with an AID system — not just your blood sugar numbers. If you're struggling with certain burdens early on, your care team can step in sooner to help address them, making it more likely you'll stick with the technology and benefit long-term.